Nasdaq · Nuclear Medicine & Radiopharmaceuticals · Moderate options liquidity · Mid cap · ~$4.0B
Lantheus is riding the most powerful structural growth wave in nuclear medicine since the FDG era — PSMA PET imaging for prostate cancer detection and staging. PYLARIFY's approval transformed the diagnostic standard of care for millions of men annually, and adoption curves in academic and community imaging centers are still in the early-middle innings nationally. The radiopharmaceutical therapy (RPT) market is the next chapter: as nuclear medicine expands from diagnostic to therapeutic (treating tumors with targeted radiation), Lantheus's imaging expertise provides a natural adjacency into therapeutic tracers. Pipeline assets in prostate therapy and neurological imaging provide multiple shots on goal. PYLARIFY revenue has consistently beaten analyst expectations since launch. The imaging supply chain — cyclotrons, radiopharmacies, specialized logistics — creates significant barriers to new entrants.
This page is a living document — updated every 72 hours from the last scan. Each data point below represents one complete algorithmic snapshot.
Every setup carries risk. Here's what could move LNTH against you, plus the key stats that frame any position.
Lantheus Holdings, Inc. (LNTH) currently has an Amora Edge Score of 74/100, ranking it top 25%. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.
LNTH's historical win rate on closed Stoptions setups is 67%. Win rate is calculated as the percentage of past LNTH trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.
The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.
Every 72 hours we refresh LNTH's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If LNTH drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.
The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to LNTH: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is LNTH outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. LNTH currently scores 74.
LNTH's sector rank and percentile against other Nuclear Medicine & Radiopharmaceuticals tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Nuclear Medicine & Radiopharmaceuticals Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.
Educational content only — not personalized investment advice. Options carry substantial risk.
Every Friday at 4:30 PM ET — trade of the week, signals in motion, sector spotlight, methodology read. 4-minute read. Free.
No spam. One email Friday afternoon. Unsubscribe in one click.